132 related articles for article (PubMed ID: 2219273)
1. Modulation of experimental cyclosporine nephrotoxicity by inhibition of thromboxane synthesis.
Petric R; Freeman D; Wallace C; McDonald J; Stiller C; Keown P
Transplantation; 1990 Oct; 50(4):558-63. PubMed ID: 2219273
[TBL] [Abstract][Full Text] [Related]
2. The relationship of urinary thromboxane excretion to cyclosporine nephrotoxicity.
Schnabel FR; Wait RB; Kahng KU
Transplantation; 1991 Mar; 51(3):686-9. PubMed ID: 2006526
[TBL] [Abstract][Full Text] [Related]
3. The role of eicosanoids in cyclosporine nephrotoxicity in the rat.
Erman A; Chen-Gal B; Rosenfeld J
Biochem Pharmacol; 1989 Jul; 38(13):2153-7. PubMed ID: 2735953
[TBL] [Abstract][Full Text] [Related]
4. Reduction of chronic ciclosporin nephrotoxicity by thromboxane synthase inhibition with OKY-046.
Kim YJ; Park YH; Moon HK
Kidney Blood Press Res; 1997; 20(1):38-43. PubMed ID: 9192909
[TBL] [Abstract][Full Text] [Related]
5. Effect of thromboxane synthetase inhibition and angiotensin converting enzyme inhibition on acute cyclosporin A nephrotoxicity.
Grieve EM; Hawksworth GM; Simpson JG; Whiting PH
Biochem Pharmacol; 1990 Nov; 40(10):2323-9. PubMed ID: 2244933
[TBL] [Abstract][Full Text] [Related]
6. Selective enhancement of thromboxane in macrophages and kidneys in cyclosporine-induced nephrotoxicity. Dietary protection by fish oil.
Rogers TS; Elzinga L; Bennett WM; Kelley VE
Transplantation; 1988 Jan; 45(1):153-6. PubMed ID: 3422115
[TBL] [Abstract][Full Text] [Related]
7. Effect of cyclosporine on urinary prostanoid excretion, renal blood flow, and glomerulotubular function.
Petric R; Freeman D; Wallace C; McDonald J; Stiller C; Keown P
Transplantation; 1988 May; 45(5):883-9. PubMed ID: 3368946
[TBL] [Abstract][Full Text] [Related]
8. Evidence that renal prostaglandin and thromboxane production is stimulated in chronic cyclosporine nephrotoxicity.
Coffman TM; Carr DR; Yarger WE; Klotman PE
Transplantation; 1987 Feb; 43(2):282-5. PubMed ID: 3810836
[TBL] [Abstract][Full Text] [Related]
9. Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporin A nephrotoxicity.
Benigni A; Chiabrando C; Piccinelli A; Perico N; Gavinelli M; Furci L; Patino O; Abbate M; Bertani T; Remuzzi G
Kidney Int; 1988 Aug; 34(2):164-74. PubMed ID: 3184595
[TBL] [Abstract][Full Text] [Related]
10. Modification of experimental nephrotoxicity with fish oil as the vehicle for cyclosporine.
Elzinga L; Kelley VE; Houghton DC; Bennett WM
Transplantation; 1987 Feb; 43(2):271-4. PubMed ID: 3810835
[TBL] [Abstract][Full Text] [Related]
11. Thromboxane receptor blockade improves cyclosporine nephrotoxicity in rats.
Spurney RF; Mayros SD; Collins D; Ruiz P; Klotman PE; Coffman T
Prostaglandins; 1990 Feb; 39(2):135-46. PubMed ID: 2138344
[TBL] [Abstract][Full Text] [Related]
12. The protective effects of the thromboxane synthetase inhibitor Dazmegrel on nephrotoxicity in cyclosporine-treated rats.
Gladue RP; Newborg MF
Transplantation; 1991 Nov; 52(5):837-41. PubMed ID: 1949170
[TBL] [Abstract][Full Text] [Related]
13. The reversal of experimental cyclosporin A nephrotoxicity by thromboxane synthetase inhibition.
Grieve EM; Hawksworth GM; Simpson JG; Whiting PH
Biochem Pharmacol; 1993 Mar; 45(6):1351-4. PubMed ID: 8466554
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine-induced hypertension in sheep. The role of thromboxanes.
Tresham JJ; Whitworth JA; Scoggins BA; Bennett WM
Transplantation; 1990 Jan; 49(1):144-8. PubMed ID: 2405549
[TBL] [Abstract][Full Text] [Related]
15. Prevention of experimental cyclosporine nephrotoxicity by dietary supplementation with LSL 90202, a lysine salt of eicosapentaenoic acid. Role of thromboxane and prostacyclin in renal tissue.
Torras J; Valles J; Sanchez J; Sabate I; Seron D; Carrera M; Castelao AM; Herrero I; Puig-Parellada P; Alsina J
Nephron; 1994; 67(1):66-72. PubMed ID: 8052370
[TBL] [Abstract][Full Text] [Related]
16. Thromboxane receptor blockade attenuates the toxic effect of cyclosporine in experimental renal transplantation.
Rossini M; Belloni A; Remuzzi G; Perico N
Circulation; 1990 Jan; 81(1 Suppl):I61-7; discussion I68. PubMed ID: 2136819
[TBL] [Abstract][Full Text] [Related]
17. Functional significance of exaggerated renal thromboxane A2 synthesis induced by cyclosporin A.
Perico N; Benigni A; Zoja C; Delaini F; Remuzzi G
Am J Physiol; 1986 Oct; 251(4 Pt 2):F581-7. PubMed ID: 3094383
[TBL] [Abstract][Full Text] [Related]
18. Effect of cyclooxygenase and thromboxane synthetase inhibition on furosemide-stimulated plasma renin activity.
Datar S; McCauley FA; Wilson TW
Can J Physiol Pharmacol; 1987 Jan; 65(1):80-3. PubMed ID: 3105853
[TBL] [Abstract][Full Text] [Related]
19. Nephrotoxicity of cyclosporine: the role of platelet-activating factor and thromboxane.
dos Santos OF; Boim MA; Barros EJ; Pirotzky E; Braquet P; Schor N
Lipids; 1991 Dec; 26(12):1320-3. PubMed ID: 1819724
[TBL] [Abstract][Full Text] [Related]
20. Volume-induced natriuresis in healthy women: renal metabolism of prostacyclin and thromboxane, and physiological role of prostanoids.
Agnoli GC; Borgatti R; Cacciari M; Lenzi P; Marinelli M; Stipo L
Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):95-103. PubMed ID: 11237476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
